Lv41
444 积分 2025-03-04 加入
Targeted Management: Unlocking the Crucial Role of PROTACs in Cancer Treatment
1小时前
已完结
Development of PROTACS degrading KRAS and SOS1
2小时前
求助中
Corrigendum to “Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activity” [Bioorgan. Chem. 117 (2021) 105447]
2小时前
已关闭
A Potent SOS1 PROTAC Degrader with Synergistic Efficacy in Combination with KRASG12C Inhibitor
2小时前
已完结
Pan-KRAS destruction with a single PROTAC
2小时前
已完结
Discovery of highly potent and selective KRASG12C degraders by VHL-recruiting PROTACs for the treatment of tumors with KRASG12C-Mutation
2小时前
已完结
Design, synthesis and biological evaluation of KRASG12C-PROTACs
2小时前
已完结
Discovery of a Potent, Cooperative, and Selective SOS1 PROTAC ZZ151 with In Vivo Antitumor Efficacy in KRAS-Mutant Cancers
2小时前
已完结
Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRASG12D
2小时前
已完结
Development of a Commercial Manufacturing Process for Vepdegestrant, an Orally Bioavailable PROTAC Estrogen Receptor Degrader for the Treatment of Breast Cancer
5小时前
已完结
皖公网安备34019202002308
